Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407370
Max Phase: Preclinical
Molecular Formula: C34H41N3O6
Molecular Weight: 587.72
Molecule Type: Protein
Associated Items:
ID: ALA2407370
Max Phase: Preclinical
Molecular Formula: C34H41N3O6
Molecular Weight: 587.72
Molecule Type: Protein
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C)[C@@H](Oc1ccc(C=O)cc1)c1ccccc1
Standard InChI: InChI=1S/C34H41N3O6/c1-23(2)20-29(37(3)4)32(39)36-30(33(40)35-28(34(41)42-5)21-24-12-8-6-9-13-24)31(26-14-10-7-11-15-26)43-27-18-16-25(22-38)17-19-27/h6-19,22-23,28-31H,20-21H2,1-5H3,(H,35,40)(H,36,39)/t28-,29-,30-,31-/m0/s1
Standard InChI Key: SSCUAVFHTLAVLS-ORYMTKCHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 587.72 | Molecular Weight (Monoisotopic): 587.2995 | AlogP: 3.98 | #Rotatable Bonds: 15 |
Polar Surface Area: 114.04 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.79 | CX Basic pKa: 7.80 | CX LogP: 5.00 | CX LogD: 4.46 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.20 | Np Likeness Score: 0.35 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):